190 filings
8-K
TENX
Tenax Therapeutics Inc
13 Jun 24
Departure of Directors or Certain Officers
4:32pm
8-K
TENX
Tenax Therapeutics Inc
14 May 24
Tenax Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
9:01am
8-K
TENX
Tenax Therapeutics Inc
28 Mar 24
Tenax Therapeutics Provides Business and Clinical Development Updates with Full Year 2023 Financial Results
8:45am
8-K
TENX
Tenax Therapeutics Inc
23 Feb 24
Other Events
4:30pm
8-K
TENX
Tenax Therapeutics Inc
20 Feb 24
Tenax Therapeutics Announces Global License Amendment that Significantly Expands Rights to Levosimendan
8:33am
8-K
1fo8nx
12 Feb 24
Tenax Therapeutics Announces Pricing of Approximately $9 Million Public Offering
4:46pm
8-K
l64ufnn
8 Feb 24
Over 40 sites (U.S. and Canada) have agreed to participate in the LEVEL study
12:00am
8-K
6bidmi
6 Feb 24
Other Events
8:56am
8-K
8zw9chd 0s70gw
19 Jan 24
Other Events
4:30pm
8-K
u3bq1f qv
12 Jan 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
3q7c9n0v
5 Jan 24
Tenax Therapeutics Announces Reverse Stock Split
4:46pm
8-K
hcf0lr
1 Dec 23
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
y2sf5uyyzw91
13 Nov 23
Other Events
9:10am
8-K
0p4pmugi56g702rq
29 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:11pm
8-K
t68sxyx1erouumi60
15 Aug 23
Amendments to Articles of Incorporation or Bylaws
4:05pm
8-K
nzfy2tl6tvsl
19 Jul 23
Other Events
4:30pm
8-K
vnrclsb2g1in7ch 96
13 Jun 23
Submission of Matters to a Vote of Security Holders
4:10pm
8-K
12etb0eqnwumgiw2
31 May 23
Other Events
4:10pm
8-K
3igfggm 8ngoy
13 Apr 23
Tenax Therapeutics Provides 2023 Business Update
9:00am
8-K
r0sozf8
30 Mar 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:01am